Kidney Week 2026 abstracts show that AMKD progresses quickly in routine practice, with or without diabetes, despite background CKD therapy.
|Articles|April 4, 2017
Infographic: Low Health Spenders Report Fewer Access Problems, Better Health
Author(s)Christina Mattina
Low spenders, defined as the bottom 50% of the population when ranked by healthcare expenditures, are responsible for just 2.8% of US healthcare spending.
Advertisement
The majority of research on healthcare expenditures focuses on high-needs, high-cost patients, particularly the group of Americans who are responsible for the top 1% of expenditures. However, a new study in Health Affairs shines a spotlight on the often-overlooked population of low spenders and finds that they tend to be younger, healthier, and better able to access healthcare.
For more on low spenders, including their age demographics and annual out-of-pocket costs, see the infographic below.
Advertisement
Related to this article
Insurance barriers were the top reason 4 in 10 people prescribed long-acting PrEP at a Missouri clinic never received it, an IDWeek 2026 poster found.
A retrospective study suggests strength exercise may be a safer option than endurance exercise for some people with ACM.
Infant flu protection from maternal vaccination varied by timing, while pediatric vaccination fell to 49.4%, experts report at IDWeek 2026.
The NCCN’s latest esophageal/EGJ guidance raises durvalumab plus FLOT to a category 2A recommendation for PD-L1–negative, diffuse-type disease.
Legal and clinical experts examined the US medical aid in dying framework, its limits, and ethical debates.
The pilot pairs grocery stipends and community health worker support with members who have unmanaged diabetes and unmet social needs.
Speakers at IDWeek 2026 urged shifting global health partnerships from donor-recipient models to shared, locally led ownership as funding contracts.
Advertisement
Advertisement
Trending on AJMC
1
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
2
Extension Studies in TPIP Show Promise in PAH, PH-ILD
3
Inhaled Amikacin Raises Culture Conversion in New MAC Lung Disease
4
Bronchiectasis GWAS Highlights Candidate Targets Shared With COPD
5